Production (Stage)
MoonLake Immunotherapeutics
MLTX
$46.88
-$1.95-3.99%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.17% | -9.29% | -4.98% | -4.98% | 7.05% |
| Total Receivables | 5.09% | 18.12% | 43.55% | 12.09% | 41.54% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -1.16% | 46.51% | 3.76% | 205.71% | 139.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.74% | -7.42% | -4.58% | -3.02% | 7.67% |
|
|
|||||
| Total Current Assets | 6.74% | -7.42% | -4.58% | -3.02% | 7.67% |
| Net Property, Plant & Equipment | -9.45% | -4.91% | -0.88% | -8.12% | 6.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -50.00% | -34.65% | -24.99% |
| Total Assets | 6.97% | -7.77% | -4.89% | -3.41% | 7.14% |
|
|
|||||
| Total Accounts Payable | -93.68% | 56.65% | -19.84% | -13.53% | -37.37% |
| Total Accrued Expenses | 0.37% | 12.32% | 80.92% | 56.60% | -21.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.37% | -5.05% | 9.32% | 1.33% | 8.89% |
| Total Finance Division Other Current Liabilities | 247.61% | 32.53% | -41.57% | -20.66% | 183.99% |
| Total Other Current Liabilities | 247.61% | 32.53% | -41.57% | -20.66% | 183.99% |
| Total Current Liabilities | 6.75% | 11.87% | 63.50% | 37.84% | -10.59% |
|
|
|||||
| Total Current Liabilities | 6.75% | 11.87% | 63.50% | 37.84% | -10.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -21.65% | -24.70% | -4.28% | -14.22% | -5.70% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -13.65% | -10.69% | 28.25% | 17.12% | -20.69% |
| Total Liabilities | 302.09% | 8.06% | 52.98% | 26.56% | -10.10% |
|
|
|||||
| Common Stock & APIC | 0.48% | 0.31% | 0.50% | 0.27% | 9.87% |
| Retained Earnings | -16.95% | -24.00% | -22.89% | -18.62% | -11.72% |
| Treasury Stock & Other | -52.23% | 76.32% | -12.98% | 20.93% | 14.23% |
| Total Common Equity | -8.80% | -8.47% | -6.24% | -4.03% | 9.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.80% | -8.47% | -6.24% | -4.03% | 9.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -22.92% | -10.13% | -22.01% | -4.73% | -44.81% |
| Total Equity | -9.00% | -8.50% | -6.51% | -4.05% | 7.57% |
|
|
|||||